BioMarin Pharmaceutical Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for PALYNZIQ® ...
San Antonio company with A+ BBB rating and 100% close rate publishes most complete guide to selling promissory notes in ...
A Slidell mother says a free program helped save her from a life of substance abuse. Now, she's encouraging others with the ...
Warriors Heart highlights how service dog training can help military, veterans and first responders rebuild lives after ...
Community leaders, mental health professionals, and public safety officials are teaming up Saturday for a double summit on ...
Onvuzosiran achieved significant and durable reductions of plasma kallikrein levels with a favorable safety profile in Phase 1/2 – SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results